Verve Therapeutics (NASDAQ:VERV) ranks 4th among the best NASDAQ stocks under $5, focusing on innovative gene-editing for cardiovascular disease. Despite a cooling labor market, economists remain positive about the economy's growth, aided by AI technology advancements.